Yegya-Raman N, Friedes C, Sun L, Iocolano M, et al. Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System. Clin Lung Cancer 2023;24:474-482.
PMID: 37076396